ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T Cell Imaging
News
ImaginAb, Inc., a biotechnology company developing powerful antibody technology for in vivo imaging, has announced it has entered into an exclusive technology development partnership with Novotectid GmbH, for the production ... Read more